Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients

Background: The effect of direct oral anticoagulants (DOAC) on laboratory tests dependent on the production of their targets, factor IIa and factor Xa, is a well-known problem and can cause both false positive and negative results. In particular, the situation in patients who develop lupus anticoagu...

Descripción completa

Detalles Bibliográficos
Autores principales: Úlehlová, Jana, Piskláková, Barbora, Ivanovová, Eliška, Procházková, Jana, Bradáčová, Pavla, Kvasnička, Aleš, Friedecký, David, Slavík, Luděk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623477/
https://www.ncbi.nlm.nih.gov/pubmed/34829374
http://dx.doi.org/10.3390/diagnostics11112027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623477/
https://www.ncbi.nlm.nih.gov/pubmed/34829374
http://dx.doi.org/10.3390/diagnostics11112027

Ejemplares similares